Markets

Insider Trading

Hedge Funds

Retirement

Opinion

5 Best Medical Device Stocks To Buy Now

In this article, we discuss 5 of the best medical device stocks to buy now. If you want to go through our detailed medical technology industry discussion, head directly to the 14 Best Medical Device Stocks To Buy Now.

5. Boston Scientific Corporation (NYSE:BSX)

Number of Hedge Fund Holders: 71

Boston Scientific Corporation (NYSE:BSX), headquartered in Delaware, functions as a biomedical and biotechnology engineering company, as well as a multinational producer of medical devices utilized across diverse interventional medical specialties. These specialties include interventional radiology, interventional cardiology, peripheral interventions, and oncology, among others.

A top contender in its sector, Boston Scientific Corporation (NYSE:BSX) successfully secured billions of dollars in debt within a week in February 2024. Moreover, the company’s shares are on average rated as Strong Buy.

As of Q4 2023 end, 71 out of the 933 hedge funds profiled by Insider Monkey had held a stake in Boston Scientific Corporation (NYSE:BSX). Ken Griffin’s Citadel Investment Group was the biggest Boston Scientific Corporation (NYSE:BSX) shareholder through its $519 million investment.

4. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 81

Johnson & Johnson (NYSE:JNJ) is a global healthcare company committed to researching, developing, manufacturing, and distributing healthcare products worldwide. On November 7, 2023, Johnson & Johnson’s (NYSE:JNJ) MedTech unit announced its plan to submit an application to the U.S. Food & Drug Administration in the second half of 2024 to initiate clinical trials for its robotic surgical system, Ottava. This surgical robot integrates four robotic arms into a standard-sized surgical table and has the ability to seamlessly reposition a patient without interrupting the ongoing surgical procedure, according to the company’s statement.

81 out of the 933 hedge funds covered by Insider Monkey’s Q4 2023 research had bought Johnson & Johnson (NYSE:JNJ)’s shares. Ken Fisher’s Fisher Asset Management was the biggest investor, owning 6.3 million shares that are worth $996 million.

3. Intuitive Surgical, Inc. (NASDAQ:ISRG)

Number of Hedge Fund Holders: 82

Intuitive Surgical, Inc. (NASDAQ:ISRG), headquartered in the United States, is dedicated to developing, manufacturing, and promoting robotic products aimed at improving clinical outcomes for patients through minimally invasive surgery, notably through its flagship product, the da Vinci Surgical System. This system comprises a surgeon’s console, a patient-side cart equipped with four robotic arms, a 3D vision system, and proprietary instruments.

In the fourth quarter of 2023, the company continued its growth trajectory, with procedures performed using the DaVinci platform increasing by 21%.

According to Insider Monkey’s tracking of 933 hedge funds for their fourth-quarter 2023 investments, 82 held shares in Intuitive Surgical, Inc. (NASDAQ: ISRG). The largest hedge fund investor in Intuitive Surgical, Inc. (NASDAQ:ISRG) is Ken Fisher’s Fisher Asset Management, holding a stake valued at $1.5 billion.

2. Danaher Corporation (NYSE:DHR)

Number of Hedge Fund Holders: 90

Founded in 1984 by brothers Steven and Mitchell Rales, Danaher Corporation (NYSE: DHR) is a diversified American conglomerate with a significant global presence. Based in Washington, D.C., the company specializes in designing, manufacturing, and marketing medical, industrial, and commercial products and services. Danaher Corporation (NYSE: DHR) operates through three distinct segments: Life Sciences, Diagnostics, and Environmental & Applied Solutions.

Insider Monkey dug through 933 hedge fund Q4 2023 shareholdings to find 90 Danaher Corporation (NYSE:DHR) investors. Ken Fisher’s Fisher Asset Management owned the largest stake which was worth $977 million.

1. Thermo Fisher Scientific Inc. (NYSE:TMO)

Number of Hedge Fund Holders: 109

Headquartered in Waltham, Massachusetts, Thermo Fisher Scientific Inc. (NYSE:TMO). is a leading American provider of analytical instruments, life sciences solutions, specialty diagnostics, laboratory, pharmaceutical, and biotechnology services. The company was formed in 2006 through the merger of Thermo Electron and Fisher Scientific.

On February 1, RBC Capital analysts reaffirmed an Outperform rating and set a $642 price target for Thermo Fisher Scientific Inc. (NYSE:TMO).

In the fourth quarter, a total of 111 hedge funds held long positions in Thermo Fisher Scientific Inc. (NYSE:TMO), with a combined stake value reaching $10.3 billion.

Disclosure: None. You can also take a look at 12 Best News and Digital Media Stocks To Buy and 11 Best Brewery and Distillery Stocks to Buy Now.

The $250 Trillion AI Hype is Real. A few years from now, you’ll probably wish you’d bought this stock.

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

When Jeff Bezos said that one breakthrough technology would shape Amazon’s destiny, even Wall Street’s biggest analysts were caught off guard.

Fast forward a year and Amazon’s new CEO Andy Jassy described generative AI as a “once-in-a-lifetime” technology that is already being used across Amazon to reinvent customer experiences.

At the 8th Future Investment Initiative conference, Elon Musk predicted that by 2040 there would be at least 10 billion humanoid robots, with each priced between $20,000 and $25,000.

Do the math. According to Musk, this technology could be worth $250 trillion by 2040.

Put another way, that’s roughly equal to:

  • 175 Teslas
  • 107 Amazons
  • 140 Metas
  • 84 Googles
  • 65 Microsofts
  • And 55 Nvidias

And here’s the wild part — this $250 trillion wave isn’t tied to one company, but to an entire ecosystem of AI innovators set to reshape the global economy.

It’s a leap so massive, it could reshape how businesses, governments, and consumers operate worldwide.

Even if that $250 trillion figure sounds ambitious, major firms like PwC and McKinsey still see AI unlocking multi-trillion-dollar potential.

How could anything be worth that much?

The answer lies in a breakthrough so powerful it’s redefining how humanity works, learns, and creates.

And this breakthrough has already set off a frenzy among hedge funds and Wall Street’s top investors.

What most investors don’t realize is that one under-owned company holds the key to this $250 trillion revolution.

In fact, Verge argues this company’s supercheap AI technology should concern rivals.

Before I reveal the details, let’s talk about how some of the richest people on the planet are positioning themselves.

  • Bill Gates sees artificial intelligence as the “biggest technological advance in my lifetime,” more transformative than the internet or personal computer, capable of improving healthcare, education, and addressing climate change.
  • Larry Ellison — through Oracle, is spending billions on Nvidia chips and partnering with Cohere to embed generative AI across Oracle’s cloud and apps.
  • Warren Buffett — not known for tech hype — says this breakthrough could have a ‘hugely beneficial social impact.

When billionaires from Silicon Valley to Wall Street line up behind the same idea — you know it’s worth paying attention to.

Even as we admire what Tesla, Nvidia, Alphabet, and Microsoft have built, we believe an even greater opportunity lies elsewhere…

But the real story isn’t Nvidia — it’s a much smaller company quietly improving the critical technology that makes this entire revolution possible.

And judging by what I’m hearing from both Silicon Valley insiders and Wall Street veterans…

This prediction might not be bold at all:

A few years from now, you’ll wish you’d owned this stock.

The best part? You can discover everything about this company and its groundbreaking technology right now.

I’ve compiled everything you need to know about this groundbreaking company in a detailed, members-only report.

Trust me — you’ll want to read this report before putting another dollar into any tech stock.

For a ridiculously low price of just $9.99 a month, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single fast food meal!

Here’s what to do next:

1. Subscribe to our Premium Readership Newsletter for just $9.99 a month. (33% Off – was $14.99).

2. Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

<b>Cancel anytime.</b> Turn off auto-renewal via our website with just a click.

 

Buy This $3 Stock Now Before the 400% Surge Begins

Dr. Inan Dogan

Dr. Ian Dogan

Co-Founder and Research Director at Insider Monkey

My name is Inan Dogan. I’m the co-founder and Research Director of Insider Monkey. I have an important message for you today.

Since March 2017, my stock picks have returned 16.5% annually. Today, I’ve found an opportunity even bigger than my British American Tobacco call.

Two years ago, Wall Street wrote off British American Tobacco (BTI) as a “melting ice cube.” The stock had crashed 40% from its peak, and consensus said the business was dying.

We looked under the cover and realized they were wrong.

We alerted our subscribers, and BTI returned 90% in just 16 months.

Now if you had invested just $10,000 in BTI in June 2024, you’d be sitting on $19,000 in October 2025.

Today, we have identified a nearly identical pattern in a digital-first giant trading at $3.

While the market panics over a surface-level revenue decline, our PhD-led research shows management has actually surgically cut $100 million in waste to focus on high-margin growth.

This pattern is a hallmark of our 16.5% annual return track record. The current opportunity offers a 400% upside potential—dwarfing even our 90% BTI return.

Get the ticker for our new “Underdog” pick and the full BTI case study for just 99 cents.

This exclusive offer is for NEW newsletter subscribers ONLY! Join our Premium Readership Newsletter for only $0.99 and become part of a savvy investor community.!

This offer vanishes in 7 days, so don’t miss your chance to lock in market beating returnsSign up NOW! The monthly newsletter comes with a 30-day, no-risk money-back guarantee. This offer is available to the first 1000 new investors who respond.

Regular price $9.99/mo. Cancel anytime.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

1. Head over to our website and subscribe to our Premium Readership Newsletter for just $0.99.

2. Enjoy a month of ad-free browsing, exclusive access to our in-depth report on the Trump tariff and nuclear energy company as well as the revolutionary AI-robotics company, and the upcoming issues of our Premium Readership Newsletter.

3. Sit back, relax, and know that you’re backed by our ironclad 30-day money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Regular price $9.99/mo. Cancel anytime.